Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract

NCT05794841 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2023-04-03

No results posted yet for this study

Summary

This is a prospective, multi-center, observational cohort study and seeks to enroll 20000 patients with one malignant tumor of digestive tract or healthy individual.

This study collected tongue coating samples non-invasively and analyzed the tongue coating metaproteomics, metagenomics and metabolomics profiles of patients with gastrointestinal malignancies.

The performance characteristics(sensitivity and specificity) of tongue coating morphology, metaproteomics, metagenomics and metabolomics tests for detection of gastrointestinal malignancies are evaluated in comparison to pathology.

Conditions

  • Malignant Tumors of Digestive Tract

Interventions

DIAGNOSTIC_TEST

Tongue coating sample collection and multi-omics analysis

Tongue coating sample collection and multi-omics analysis for building a diagnostic model

Sponsors & Collaborators

  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Liaoning Cancer Hospital & Institute

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Fujian Cancer Hospital

    collaborator OTHER_GOV
  • Sun Yat-sen University

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Sichuan Cancer Hospital and Research Institute

    collaborator OTHER
  • Zhejiang Provincial Tongde Hospital

    collaborator OTHER
  • Yuhang District Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • The First People's Hospital of Yuhang District

    collaborator OTHER
  • The First Affiliated Hospital of Anhui University of Chinese Medicine

    collaborator OTHER
  • BGI-Shenzhen

    collaborator INDUSTRY
  • Shangyu People's Hospital

    collaborator OTHER
  • Xianju People's Hospital

    collaborator UNKNOWN
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • Xiangdong Cheng, PhD. · Zhejiang Cancer Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-03-31
Completion
2025-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794841 on ClinicalTrials.gov